Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03234062 · ClinicalTrials.gov registry record · NA

Developing a Biomarker Panel to Assess Choline Nutritional Status

A NA study of Healthy, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT03234062 is a NA study of Healthy that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 16 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03234062, a NA study of Healthy, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

People who eat diets low in choline (LC) should deplete their choline (Cho) stores, and measurements of Cho pool size using isotope dilution should reflect this depletion. Investigators will identify a biomarker panel that correlates well with measured Cho pool size across the range of different degrees of depletion.The investigators propose that, as body stores of Cho diminish, cells and organs will reach the point when metabolism/function in the cell is altered, and that this will result in a progression of changes in biomarkers that reflect Cho status.

Conditions Studied

Interventions

  • OTHER 25% Cho diet
  • OTHER 50% Cho diet
  • OTHER 100% Cho diet

Study Locations (1)

North Carolina

  • UNC Chapel Hill Nutrition Research Institute - Kannapolis

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2018-02-15
Est. Completion 2018-10-18
Phase NA

What the Registry Record Tells You About NCT03234062

The ClinicalTrials.gov registry entry for NCT03234062 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 3 interventions - of which 25% Cho diet is the first listed.

NCT03234062 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03234062 about?

NCT03234062 is a clinical study titled "Developing a Biomarker Panel to Assess Choline Nutritional Status". People who eat diets low in choline (LC) should deplete their choline (Cho) stores, and measurements of Cho pool size using isotope dilution should reflect this depletion. Investigators will identify a biomarker panel that correlates well with measured Cho pool size across the range of different deg...

What is the current status of trial NCT03234062?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2018-02-15. Estimated completion is 2018-10-18.

What conditions does trial NCT03234062 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT03234062?

The interventions under investigation include: 25% Cho diet (OTHER), 50% Cho diet (OTHER), 100% Cho diet (OTHER).

Who is sponsoring clinical trial NCT03234062?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03234062 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.